Second Drug for Benign Synovial Tumor Condition Wins FDA Approval
MedPage Today) -- The FDA approved the small-molecule inhibitor vimseltinib (Romvimza) for adults with symptomatic tenosynovial giant cell tumor (TGCT),...
Luz Roberie
MedPage Today) -- The FDA approved the small-molecule inhibitor vimseltinib (Romvimza) for adults with symptomatic tenosynovial giant cell tumor (TGCT),...
